Skip to main content
SpringerLink
Log in

BRL 26921: appears to prevent evolution of a threatened infarction, especially in early-treated patients

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

BRL 26921: appears to prevent evolution of a threatened infarction, especially in early-treated patients. Inpharma Wkly. 561, 6 (1986). https://doi.org/10.1007/BF03291716

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03291716

Keywords

Search

Navigation